604 – Presence of Excess Visceral Abdominal Fat Impacts MASLD in People With HIV
Background The prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a growing concern among people with HIV (PWH), driven in part by the rising prevalence of obesity. A recent study demonstrated a MASLD prevalence of 52% and an advanced fibrosis prevalence of 15% in a cohort of PWH (Gawrieh 2024). Excess visceral abdominal fat…